CardioNet
CardioNet provides real-time ambulatory cardiac monitoring and diagnostic solutions, including Mobile Cardiac Telemetry, Extended Holter, and Remote INR monitoring, serving hospitals, cardiology practices, and primary care providers through Philips Healthcare's global distribution network.
- Company typePrivate
- Founded1999
- HeadquartersConshohocken, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What CardioNet does
CardioNet provides real-time ambulatory outpatient cardiac monitoring and diagnostic solutions, operating today as a subsidiary within Philips Healthcare's Ambulatory Monitoring and Diagnostics division (formerly BioTelemetry). The company's core technology stack comprises three flagship product lines: Mobile Cardiac Telemetry (MCOT), which delivers real-time continuous wireless ECG transmission for proactive patient management outside hospital settings; the Extended Holter (ePatch) for long-term continuous ECG monitoring; and Remote INR monitoring for at-home blood coagulation testing in warfarin patients. EMR integration capabilities are layered across these products to feed monitoring data directly into provider electronic medical record systems.
Revenue is generated through a subscription and per-test service billing model, with B2B contracts sold to healthcare systems, hospitals, cardiology and electrophysiology practices, and primary care providers. The go-to-market motion is enterprise field sales, executed primarily through Philips' global healthcare distribution network, complemented by a direct patient portal (myheartmonitor.com) that enables self-service access for individual consumers. The business is positioned within Philips as the "#1 patient care management ecosystem," integrating in-hospital diagnostic cardiology with at-home ambulatory monitoring across stroke, ED discharge, and primary care clinical pathways.
The business model combines recurring monitoring service contracts with diagnostic test billing, supported by AI-powered analytics (automated triage and predictive analytics) that target reductions in provider alert fatigue. Geographic reach is global via Philips' North America, Europe, and Asia distribution infrastructure. The headcount is 501-1,000 employees, anchored at headquarters in the Philadelphia / Conshohocken, PA area. CardioNet's competitive moat rests heavily on Philips' distribution scale, regulatory-cleared medical device status, embedded EMR integrations that create switching costs, and accumulated proprietary ECG datasets feeding continuous analytics.
CardioNet firmographics
Firmographics- Name
- CardioNet
- Legal name
- CardioNet
- Website
- https://cardionet.com
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- CardioNet provides real-time ambulatory cardiac monitoring and diagnostic solutions, including Mobile Cardiac Telemetry, Extended Holter, and Remote INR monitoring, serving hospitals, cardiology practices, and primary care providers through Philips Healthcare's global distribution network.
- Ownership category
- akta.pro rank
CardioNet industry classification
Industry- Product category
- Remote Cardiac Monitoring Services
- NAICS
- Outpatient Care Centers (6214), Ambulatory Health Care Services (621)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders) (HLAHACAB)
- akta.pro secondary industries
- Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA), Electrophysiology (Heart Rhythm) (HLAKABAC)
Keywords
Where CardioNet is headquartered
LocationHeadquarters
- HQ city
- Conshohocken
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
CardioNet business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain
Revenue model
- Remote Patient Monitoring Services: CardioNet provides remote cardiac monitoring services to healthcare providers and health systems. Revenue is generated through healthcare service contracts, device rental/subscription models, and per-test billing for diagnostic monitoring services.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels3 records
CardioNet product offering
Product offeringCore offering
CardioNet provides real-time ambulatory outpatient cardiac monitoring solutions, delivering continuous ECG data and diagnostic services outside hospital settings. Its core offerings include Mobile Cardiac Telemetry (MCOT), Extended Holter monitoring via the ePatch device, and Remote INR monitoring for warfarin patients, all integrated with provider EMR systems to support arrhythmia detection, stroke prevention, and proactive cardiac patient management.
Product overview
CardioNet is referenced in industry context as one of the top remote patient monitoring companies, offering cardiac monitoring solutions. However, no specific CardioNet-branded products, services, or technical details are available in the provided source data. The related Philips/BioTelemetry ambulatory monitoring solutions include Mobile Cardiac Telemetry (MCOT), Extended Holter (ePatch), and Remote INR monitoring, but these are not attributed to CardioNet specifically.
Differentiator
Problem solved
Functional benefit
Products and services
- Mobile Cardiac Telemetry (MCOT) Real-time continuous cardiac monitoring service with wireless transmission of ECG data for proactive patient management outside hospital settings. Designed for healthcare providers including hospitals, cardiology practices, and primary care for arrhythmia detection and post-discharge cardiac monitoring.
- Extended Holter (ePatch) Long-term continuous ECG monitoring service via a miniaturized patch device for extended cardiac assessment beyond traditional Holter monitoring periods. Targets cardiology and electrophysiology practices requiring diagnostic-grade continuous ECG data.
- Remote INR Monitoring Remote international normalized ratio (INR) testing service for patients on warfarin therapy, enabling at-home blood coagulation monitoring. Designed for cardiology and primary care providers managing anticoagulation patients.
- EMR Integration Integration offering that connects CardioNet cardiac monitoring devices and data with hospital and practice electronic medical record systems for seamless workflow and data flow. Designed for healthcare enterprises seeking interoperability between ambulatory monitoring outputs and clinical systems.
Quantifiable outcome
- Reduction in provider alert fatigue by up to 87% through AI-powered automated triage systems
Companies that use CardioNet
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
CardioNet technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
CardioNet partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and minor.
- Philips Healthcare (Parent Company)coreCardioNet operates as a subsidiary of Philips Healthcare following the acquisition of BioTelemetry by Philips. This combination creates the #1 patient care management ecosystem, integrating Philips' hospital solutions with CardioNet's home monitoring capabilities.
- Giving it Back to KidsminorPhilips works with Giving it Back to Kids, a non-profit organization in Southeast Asia that provides life-saving surgeries and medical care for children with heart disease. CardioNet cardiac monitoring solutions support this charitable initiative.
Scale indicators3 records
Recent moves6 records
Expansion highlights4 records
CardioNet competitors and assessment
Company assessmentBroad incumbents
- Koninklijke Philips (Philips Healthcare): CardioNet's parent company and broader healthcare technology incumbent offering in-hospital diagnostic cardiology, ECG, and patient monitoring solutions that compete in adjacent but overlapping categories.
- Nihon Kohden: Japanese medical electronics company offering Holter monitors, ECG systems, and ambulatory cardiac monitoring devices. Comparable product portfolio and enterprise healthcare channel overlap with CardioNet's Holter/MCOT line.
- Medtronic: Global medtech incumbent with cardiac rhythm management, insertable cardiac monitors (LINQ), and remote monitoring services. Competes in ambulatory and implantable cardiac monitoring across overlapping hospital and electrophysiology customers.
- Boston Scientific: Major cardiology device incumbent with rhythm management and remote monitoring (formerly Preventice BodyGuardian). Provides overlapping ambulatory cardiac telemetry and Holter offerings to the same hospital and cardiology channels.
- GE HealthCare: Diagnostic cardiology and patient monitoring incumbent with resting ECG, Holter, and hospital telemetry solutions. Competes with CardioNet for the same cardiology and hospital system buyers.
- Abbott: Cardiovascular franchise including insertable cardiac monitors (Confirm Rx, Jot Dx) and remote monitoring. Competes with CardioNet in electrophysiology and AFib detection across hospitals and cardiology practices.
Others
- Apple: Consumer wearable incumbent (Apple Watch) with FDA-cleared ECG and AFib detection features at massive installed base. Adjacent ecosystem participant increasingly competing for atrial fibrillation screening at the consumer/primary care interface.
Direct peers
- iRhythm Technologies: Clinical ambulatory cardiac monitoring company best known for the Zio patch. Competes directly with CardioNet's MCOT and ePatch Holter products for cardiology practice and hospital enterprise contracts.
Emerging players
- Huxley Medical: Emerging cardiac wearable/remote monitoring company focused on sleep-apnea and cardiac arrhythmia detection. Comparable technology approach in remote cardiac diagnostics through miniaturized wearables.
- AliveCor: Consumer and clinical ECG company with KardiaMobile devices offering single-lead ECG and AFib detection. An emerging adjacent player in cardiac monitoring intersecting the lower-acuity end of CardioNet's screening market.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
CardioNet social profiles
Digital presenceCardioNet financial estimates
Financial estimateRevenue estimate
Valuation estimate
CardioNet leadership team
Management profileNumber of profiles
Profiles6 records
CardioNet funding detail
Funding detailFunding overview
Funding rounds4 records
Investors7 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CardioNet M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CardioNet
What does CardioNet do?
CardioNet provides real-time ambulatory outpatient cardiac monitoring solutions, delivering continuous ECG data and diagnostic services outside hospital settings. Its core offerings include Mobile Cardiac Telemetry (MCOT), Extended Holter monitoring via the ePatch device, and Remote INR monitoring for warfarin patients, all integrated with provider EMR systems to support arrhythmia detection, stroke prevention, and proactive cardiac patient management.
Is CardioNet a public or private company?
CardioNet is a private company. It is classified as corporate owned and is currently operating.
When was CardioNet founded?
CardioNet was founded in 1999. It employs 501 to 1,000 people.
Where is CardioNet based?
CardioNet is headquartered in Conshohocken, United States, in the North America region.
How does CardioNet make money?
One revenue line is on record: remote Patient Monitoring Services.
Who are CardioNet's main competitors?
Broad incumbents on record are Koninklijke Philips (Philips Healthcare), Nihon Kohden, Medtronic, Boston Scientific, GE HealthCare and Abbott. Apple is listed as an others. iRhythm Technologies is listed as a direct peer. Emerging players are Huxley Medical and AliveCor.
Does CardioNet have an API?
No public API is recorded for CardioNet.
What industry is CardioNet in?
CardioNet's product category is Remote Cardiac Monitoring Services. Its primary akta.pro industry code is HLAHACAB, Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders), with a secondary code of HLALAFAA, Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity). Its NAICS code is 6214 and its SIC code is 3845.